Search Results

Genetown

Leukocare Announces USD 17.5 Million Financing Round to Further Expand US Business and Bioinformatics Activities

Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, announced the closing of a USD 17.5 million financing, led by Petrichor Healthcare Capital Management, with participation from existing Leukocare shareholders.

June 23, 2021

·

4 min read

Genetown

Rentschler Biopharma and Leukocare extend service offering with joint U.S. site

Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clients

March 22, 2021

·

6 min read

Business

Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area

Leukocare AG, a German biotechnology company specialized in formulation development for biologics, viral vectors and vaccines, announced the opening of its development laboratories and offices in Milford, MA, USA.

January 11, 2021

·

3 min read

Business

ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine

Italian ReiThera Srl., German LEUKOCARE AG, and Belgian Univercells S.A., announced a strategic collaboration for the development and large-scale manufacturing of a novel adenoviral vector-based vaccine against COVID-19.

April 27, 2020

·

6 min read

Rentschler Biopharma Inc.

Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including advanced therapies, as well as related consulting activities, project management and regulatory support.

Business

LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations for the development of value-added anti-infective therapies

LEUKOCARE AG and Xellia Pharmaceuticals, have entered into a global strategic partnership, where both companies will collaborate closely to discover innovative and superior formulations to support the development of Xellia’s pipeline of value-added antibiotic and antifungal products which are intended to enhance patient care.

September 10, 2018

·

3 min read

Business

German Biotech Receives $17.5M to Expand in U.S.

German biotechnology firm LEUKOCARE, which has operations in Milford, Connecticut, has announced the closing of $17.5 million financing round from New York investment firm Petrichor Healthcare Capital Management.

June 24, 2021

·

2 min read

·

Vanessa Doctor, RN

LEUKOCARE Continues To Expand And Invests In Research And Development

September 14, 2017

·

2 min read

Business

Rentschler Biopharma and Leukocare Demonstrate Success of Strategic Alliance for Biopharmaceutical Development and Formulation

Integration of best-in-class formulation in the biopharmaceutical development process adds significant value and improves speed to market

March 9, 2018

·

3 min read

Rentschler Biopharma and LEUKOCARE to announce findings of recent international Drug Product Formulation Survey at BIO-Europe® 2018

The survey provides latest insights into the status quo and future of drug product formulation and its potential to refine all steps in the biopharmaceutical value chain.

October 24, 2018

·

3 min read